ARCHIVES

Two Phase III Afatinib Trials Demonstrate Prolonged Survival

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Pelayo Correa Heads LSU Cancer Center; Foundation to Honor Feinstein, Mack

September 5, 1997

Glaxo, Mass General Begin Phase III Trial Of Tykerb

December 29, 2006

In Brief: O’Conor Names NCI Liaison To IARC, Saunders Acting IA Director Susan Sieber DCCP Deputy

May 27, 1983

DCT Board reluctantly Okays Resources Contracts Recompetition, $6 of $10 Million Competitively

April 1, 1977

CCOPs ask NCI officials about one-year extensions.

May 20, 2005

Obey Insists NCI Pressured IARC Into Softening Report On Benzene Risk

August 20, 1982